Target intelligence / Profile preview

SLAM family member 5-like pseudogene

Molecular classification
Other (pseudogene)
01

Overview

SLAM family member 5-like pseudogene is a non-protein-coding genomic locus that shows sequence homology to the SLAM family member 5 gene (CD84, also known as SLAMF5), which is an immune cell surface receptor. Unlike the protein-coding SLAMF5, this pseudogene does not produce a functional protein and is classified as a genomic relic without direct biological or pharmacological relevance. Pseudogenes can sometimes exert regulatory effects on functional homologs at the RNA level, but no such function has been reported for this specific locus

Beyond the preview

Go deeper on SLAM family member 5-like pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLAM family member 5-like pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call